Core Scientific, Inc.
18.09USD
-0.6400 (-3.42%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.04▼ | $0 | 0 | 0 |
| Next quarter | $-0.06▼ | $0.03 | 0 | 0 |
| Current year | $-3.88▼ | $-0.06 | 0 | 0 |
| Next year | $0.14▼ | $0.42 | 0 | 0 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.06 | $-0.04 | +0.02 (+27.2%) |
| 2026-03-31 | $-0.05 | $-0.11 | -0.06 (-119.6%) |
| 2025-12-31 | $-0.12 | $-0.18 | -0.06 (-53.4%) |
| 2025-09-30 | $0.07 | $-0.2 | -0.27 (-382.9%) |
97 ratings from 21 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $33 $42 | Aug 3, 2026 |
| Keefe, Bruyette & Woods | Upgraded from Market Perform | Outperform | $25 $28 | Jul 30, 2026 |
| Macquarie | Maintained | Outperform | $35 $38 | Jul 29, 2026 |
| Needham | Maintained | Buy | $29 $35 | Jul 29, 2026 |
| Canaccord Genuity | Maintained | Buy | $30 $36 | Jul 29, 2026 |
| Needham | Reiterated | Buy | $29 | Jul 28, 2026 |
| BTIG | Reiterated | Buy | $38 | Jul 28, 2026 |
| BTIG | Maintained | Buy | $33 $38 | Jun 25, 2026 |
| Freedom Broker | Initiated | Hold | $33 | Jun 16, 2026 |
| B. Riley Securities | Maintained | Buy | $30 $33 | May 27, 2026 |
| Jefferies | Maintained | Buy | $24 $37 | May 14, 2026 |
| BTIG | Maintained | Buy | $23 $33 | May 13, 2026 |
| Macquarie | Maintained | Outperform | $28 $35 | May 7, 2026 |
| Needham | Maintained | Buy | $23 $29 | May 7, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $25 $29 | Apr 9, 2026 |
| Canaccord Genuity | Maintained | Buy | $17 $20 | Mar 4, 2026 |
| Macquarie | Maintained | Outperform | $34 $28 | Mar 4, 2026 |
| Ladenburg Thalmann | Maintained | Buy | $24.5 $23.75 | Mar 3, 2026 |
| Needham | Upgraded from Hold | Buy | $23 | Mar 3, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $26 $25 | Mar 3, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $25 | Mar 3, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $19 $25 | Jan 27, 2026 |
| BTIG | Upgraded from Neutral | Buy | $23 | Jan 6, 2026 |
| Citizens | Upgraded from Market Perform | Market Outperform | $30 | Dec 18, 2025 |
| Bernstein | Maintained | Outperform | $17 $24 | Nov 3, 2025 |
82 filings from 13 insiders · 9 buy / 23 sell over 6m
Officers and directors of CORZ, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| DUCHENE TODD MOfficer, See remarks | Sell | 10.0k | $16.23 | $162k | Aug 31, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $17.45 | $174k | Aug 24, 2026 |
| CRAIN ELIZABETH ADirector | Buy | 6.0k | $18.33 | $110k | Aug 20, 2026 |
| WEISS ERIC STANTONDirector | Buy | 7.0k | $19.19 | $134k | Aug 18, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $20.10 | $201k | Aug 17, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $19.90 | $200k | Aug 10, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $20.39 | $222k | Aug 3, 2026 |
| ADAMS MARK WDirector | Grant | 27.6k | — | — | Jul 30, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $20.75 | $209k | Jul 27, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $22.30 | $223k | Jul 20, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $22.43 | $224k | Jul 13, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $22.63 | $226k | Jul 6, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $25.99 | $262k | Jun 29, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $29.11 | $293k | Jun 22, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $28.19 | $282k | Jun 15, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $26.64 | $268k | Jun 8, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $26.93 | $284k | Jun 1, 2026 |
| DUCHENE TODD MOfficer | Sell | 10.0k | $26.25 | $263k | May 26, 2026 |
| SMITH STEPHEN MDirector | Grant | 19.0k | — | — | May 26, 2026 |
| NYGAARD JAMES P JRChief Financial Officer | Grant | 120.1k | — | — | May 20, 2026 |
No analyst notes on CORZ yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 13 | 1 | 0 | 0 | Buy1.88 |
| 1 mo ago | 3 | 13 | 1 | 0 | 0 | Buy1.88 |
| 2 mo ago | 3 | 13 | 2 | 0 | 0 | Buy1.94 |